Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Blood|October 6, 1997
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapyG Ferrari, C Berend, J Ottinger, et al.
Virology|May 1, 1984
Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymusK J Weinhold, G Hüper, T J Matthews, et al.
Journal of Autoimmunity|January 1, 2014
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravisJ S Yi, A Guidon, S Sparks, et al.
AIDS Research and Human Retroviruses|September 1, 1990
HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptideP J Durda, L Bacheler, P Clapham, et al.
World Neurosurgery|February 26, 2022
Coupling Hematoma Evacuation with Immune Profiling for Analysis of Neuroinflammation After Primary Intracerebral Hemorrhage: A Pilot StudyJay B Lusk, Quintin J Quinones, Janet S Staats, et al.
Vaccine|October 9, 2012
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platformElizabeth S Gabitzsch, Joseph P Balint-Junior, Younong Xu, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordanceSusan S Kaplan, Guido Ferrari, Terri Wrin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Journal of Medical Virology|May 15, 2023
Evaluation of host cellular responses to Epstein-Barr virus (EBV) in adult lung transplant patients with EBV-associated diseasesLorenzo Zaffiri, Joshua E Messinger, Erika J Bush, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteersG Ferrari, W Humphrey, M J McElrath, et al.
Pageof 16